I agree that this site is using cookies. You can find further informations here.
X
Juárez-Salcedo, Luis Miguel
93  results:
Search for persons X
?
1

Loncastuximab Tesirine in the Treatment of Relapsed or Refr..:

Juárez-Salcedo, Luis Miguel ; Nimkar, Santosh ; Corazón, Ana María.
International Journal of Molecular Sciences.  25 (2024)  14 - p. 7580 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Neutropenıa Secondary to Sars-Cov2 Vaccınatıon in Post-Hema..:

JUAREZ-SALCEDO, LUIS MIGUEL ; Feijóo, Samantha ; García, Cristina...
Mediterranean Journal of Hematology and Infectious Diseases.  15 (2023)  1 - p. e2023014 , 2023
Link: https://doi.org/10.4084/..
 
?
3

Adverse events of radioimmunotherapy for non-Hodgkin lympho..:

Sharda, Esha ; Patel, Raahil S. ; Juárez-Salcedo, Luis Miguel...
Leukemia Research.  108 (2021)  - p. 106615 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis,..:

Juárez-Salcedo, Luis Miguel ; Sokol, Lubomir ; Chavez, Julio C..
Cancer Control.  25 (2018)  1 - p. 107327481877825 , 2018
Link: https://doi.org/10.1177/..
 
?
5

The role of anti-PD-1 and anti-PD-L1 agents in the treatmen..:

Juárez-Salcedo, Luis Miguel ; Sandoval-Sus, Jose ; Sokol, Lubomir..
Critical Reviews in Oncology/Hematology.  113 (2017)  - p. 52-62 , 2017
Link: https://doi.org/10.1016/..
 
?
6

Management of adverse effects of new monoclonal antibody tr..:

Conde-Royo, Diego ; Juárez-Salcedo, Luis Miguel ; Dalia, Samir
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560100/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
7

Primary Cutaneous CD8 Aggressive Epidermotropic Cytotoxic T..:

Corazón-Monzón, Ana Marèa ; Juárez-Salcedo, Luis Miguel ; Dalia, Samir
Atlas of Genetics and Cytogenetics in Oncology and Haematology.  , 2020
Link: http://hdl.handle.net/20..
 
?
8

Use of anti-CD20 therapy in follicular and marginal zone ly..:

Juárez-Salcedo, Luis Miguel ; Conde-Royo, Diego ; Quiroz-Cervantes, Keina.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216786/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
9

Histiocytic Sarcoma:

Royo, Diego Conde ; Juarez-Salcedo, Luis Miguel ; Dalia, Samir
Atlas of Genetics and Cytogenetics in Oncology and Haematology.  , 2019
Link: http://hdl.handle.net/20..
 
?
10

Interdigitating Dendritic Cell Sarcoma:

Royo, Diego Conde ; Juarez-Salcedo, Luis Miguel ; Dalia, Samir
Atlas of Genetics and Cytogenetics in Oncology and Haematology.  , 2019
Link: http://hdl.handle.net/20..
 
?
11

Indeterminate Dendritic Cell Tumor:

Royo, Diego Conde ; Juarez-Salcedo, Luis Miguel ; Dalia, Samir
Atlas of Genetics and Cytogenetics in Oncology and Haematology.  , 2019
Link: http://hdl.handle.net/20..
 
?
12

Venetoclax: evidence to date and clinical potential:

Juárez-Salcedo, Luis Miguel ; Desai, Viraj ; Dalia, Samir
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788387/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
13

Excellent outcome of hairy cell leukaemia with extensive me..:

Juárez Salcedo, Luis Miguel ; Sandoval‐Sus, Jose ; Zhang, Ling..
British Journal of Haematology.  174 (2016)  5 - p. 659-659 , 2016
Link: https://doi.org/10.1111/..
 
?
14

Survival Impact of Serum Albumin (SA) in Patients with Acqu..:

Clara, Joseph ; Dalia, Samir ; Shah, Bijal...
Clinical Lymphoma Myeloma and Leukemia.  16 (2016)  - p. S106-S107 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Successful Long-Term Use of Eltrombopag in a Patient with R..:

Luis Miguel, Juárez Salcedo ; Juan José, Gil-Fernández
Case Reports in Hematology.  2017 (2017)  - p. 1-4 , 2017
Link: https://doi.org/10.1155/..
 
1-15